AprilBio Co Ltd (397030) Stock Price & News

397030:KOSDAQ

AprilBio Co Ltd

₩43,500.00

+2.59%

(+1,100.00) 1D

Jun 16, 3:30:14 PM GMT+9 · KRW

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 397030...

Open

₩42,550

High

₩44,700

Low

₩41,600

Mkt. cap

1.02T

Avg. vol.

356.62K

Volume

255.30K

52-wk high

₩76,700

52-wk low

₩16,160

EPS

-₩447

Shares outstanding

23.41M

No. of employees

Open

₩42,550

High

₩44,700

Low

₩41,600

Mkt. cap

1.02T

Avg. vol.

356.62K

Volume

255.30K

52-wk high

₩76,700

52-wk low

₩16,160

EPS

-₩447

Shares outstanding

23.41M

No. of employees

Related stocks

Curiox BioSystems Co Ltd

₩62,000.00

-4.32%

141080

LigaChem Biosciences Inc

₩139,700.00

+5.20%

News stories

From sources across the web

Nasdaq

13 minutes ago

UK Fraud Losses Cross £1.28 Billion as Criminals Leverage AI to Target Human Behavior

Stock Titan

43 minutes ago

Space lasers for in-flight internet: Syntec Optics nears $4.3M orders

Barron's

1 hour ago

S&P 500 Futures Rise in Premarket Trading; Western Digital, Agilent Technologies Lead

Seeking Alpha

58 minutes ago

Dow Jones Quant Leaders: 3 Top Stocks As Blue Chips Rally

About AprilBio Co Ltd

CEO-

Employees27

Founded2013

Headquarters-

SectorBiotechnology

Websiteaprilbio.com

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	725.35M
Cost of goods sold	4.42M	5.92M	8.51M	4.62M
Cost of revenue	4.42M	5.92M	8.51M	4.62M
Research and development expenses	1.09B	1.77B	563.02M	1.36B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.36B	530.14M	1.23B	1.35B
Operating expense	2.65B	2.49B	1.99B	2.91B
Total operating expenses	2.66B	2.50B	2.00B	2.92B
Operating income	-2.66B	-2.50B	-2.00B	-2.19B
Other non operating income	1.38B	-4.06B	-1.05B	900.00
EBT including unusual items	-3.09B	-4.96B	-2.27B	200.99M
EBT excluding unusual items	-3.09B	-4.96B	-1.61B	200.99M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	18.74M	21.19M	35.46M	44.80M
Net income	-3.09B	-4.96B	-2.27B	200.99M
Net profit margin	-	-	-	27.71%
Earnings per share	-	-	-	-
Interest and investment income	830.16M	813.92M	759.90M	712.86M
Interest expense	-200.23M	-199.69M	-30.79M	-8.44M
Net interest expenses	629.93M	614.23M	729.11M	704.42M
Depreciation and amortization charges	177.28M	170.05M	163.16M	161.25M
EBITDA	-2.48B	-2.33B	-1.83B	-2.03B
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Ask anything